DIA 2019: PharmaVOICE Interview with Mike Nolte, CEO, Signant Health

August 9, 2019

Mike Nolte, CEO talks about Signant’s new brand and the importance of bringing empathy into clinical trials at DIA 2019 with PharmaVOICE.

Previous Article
Signant Health Raises the Bar in Ulcerative Colitis Trials with eCOA
Signant Health Raises the Bar in Ulcerative Colitis Trials with eCOA

Q&A with Katie Garner, Signant Health: Using eCOA in Ulcerative Colitis Trials for Seamless MAYO Score Calc...

Next Article
Signant Health Unveiled at DIA 2019
Signant Health Unveiled at DIA 2019

DIA 2019 Recap by Signant Health.